ClearPoint Neuro Inc vs YieldMax NVDA Option Income Strategy ETF — how do they compare? ClearPoint Neuro Inc trades at $14.56 (market cap $454.21M), while YieldMax NVDA Option Income Strategy ETF trades at $13.02. Which is the better fit depends on your goals.
| CLPT | NVDY | |
|---|---|---|
Market Cap | $454.21M | — |
Sector | Health | Income / Options Overlay |
52-Week High | $29.60 | $17.96 |
52-Week Low | $8.66 | $11.58 |
Enterprise Value | $488.79M | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NVDY trades at $13.00, up 2.12% on the day, with technical indicators showing a bullish trend but overbought conditions on short-term RSI. The ETF generates income through weekly distributions, with recent dividends ranging from $0.09 to $0.15 per share. News highlights focus on its strategy of selling NVIDIA call options to fund payouts, sacrificing some upside for yield.
The outlook hinges on NVIDIA's volatility sustaining option premiums, offering high income but capping gains. Risks include underperformance vs. NVIDIA stock and fee drag. Analyst sentiment is mixed, weighing income benefits against opportunity costs, with institutional interest driven by yield-seeking investors.
Trailing returns across standard periods
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →NVDY is an actively managed ETF that pursues a synthetic covered call strategy on NVIDIA Corporation (NVDA) stock. The fund primarily sells call options on NVDA and invests in U.S. Treasury securities and other high-quality collateral. Its goal is to generate monthly income from the option premiums. This strategy provides exposure to the high-growth potential of NVDA while seeking to deliver a high yield, though it caps the potential capital appreciation of the stock.
Read more on NVDY →